Diagnosis and treatment of gastric cancer;Diagnostik und therapie des magenkarzinoms

Deutsche Medizinische Wochenschrift

Volumn 135, Issue 34-35, 2010, Pages 1671-1682

  Lordick, F ^a   Grenacher, L ^b   Rocken C ^c   Ebert, M ^d   Moehler, M ^e   Schumacher, G ^f  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

chemotherapy; diagnosis; gastric cancer; surgery; treatment

Indexed keywords

CAPECITABINE; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROPYRIMIDINE; FLUOROURACIL; OXALIPLATIN; TRASTUZUMAB;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DYSPHAGIA; ENDOSCOPIC ECHOGRAPHY; GASTRECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; REVIEW; STOMACH CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARCINOMA, SIGNET RING CELL; CISPLATIN; ENDOSCOPY, DIGESTIVE SYSTEM; EPIRUBICIN; ESOPHAGECTOMY; FLUOROURACIL; GASTRECTOMY; GASTRIC MUCOSA; HUMANS; LAPAROSCOPY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955886374     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1262460     Document Type: Review

References (40)

1. Ajani J A., Moiseyenko V M., Tjulandin S et al. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group. J Clin Oncol 2007 25 3210-3216 (Pubitemid 47325603)
2. Al-Batran S E., Hartmann J T., Probst S et al. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 2008 26 1435-1442
3. Bang Y J., Van Cutsem E, Feyereislova A et al. Trastuzumab in combination with chemotherapy for the treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer. N Engl J Med 2010
4. Bennett C, Wang Y, Pan T. Endoscopic mucosal resection for early gastric cancer. Cochrane Database Syt Rev 2009 4 CD004276
5. Boige V, Pignon J P., Saint-Aubert B et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol 2007 25 4510
6. Cascinu S, Labianca R, Barone C et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007 99 601-607 (Pubitemid 47073541)
7. Cunningham D, Allum W H., Stenning S P. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006 355 11-20
8. Cunningham D, Starling N, Rao S et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 2008 358 36-46
9. DAngelica M, Gonen M, Brennan M F. et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004 240 808-816
10. Dank M, Zaluski J, Barone C et al. Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction. Ann Oncol 2008 19 1450-1457
11. Federaal Kenniscentrum voor de Gezondheidszorg Centre fédéral dexpertise des soins de santé. Wetenschappelijke ondersteuning van het College voor Oncologie: een nationale praktijkrichtlijn voor de aanpak van slokdarm- en maagkanker. Brüssel 21. März 2008
12. Feussner H, Omote K, Fink U et al. Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy 1999 31 342-347
13. Fiorica F, Cartei F, Enea M et al. The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev 2007 33 729-740
14. Glimelius B, Hoffman K, Graf W et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 1995 6 267-274
15. Grenacher L, Hansmann J. Radiologische Bildgebung des oberen Gastrointestinaltraktes, Teil II Magen. Radiologe 2007 47 71-88
16. Hwang S W., Lee D H., Lee S H. et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol 2010 25 512-518
17. Janunger K G., Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: a review und updated meta-analysis. Eur J Surg 2002 168 597-608
18. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma, 1st engl en. Kanehara, Tokyo 1995
19. Kang Y K., Kang W K., Shin D B. et al. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol 2009 20 666-673
20. Kwee R M., Kwee T C. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 2007 25 2107-2116
21. Lorenzen S, Hentrich M, Haberl C et al. Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. Ann Oncol 2007 18 1673-1679
22. Lordick F, Ott K, Novotny A et al. R1 resection in the surgery of upper gastrointestinal tumors: Relevance and therapeutic consequences. Chirurg 2007 78 792-801
23. Lordick F, Ott K, Weitz J, Jäger D. The evolving role of catumaxomab in gastric cancer. Expert Opin Biol Ther 2008 8 1407-1415
24. Macdonald J S., Smalley S R., Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001 345 725-30
25. Murad A M., Santiago F F., Petroianu A et al. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993 72 37-41
26. Puli S R., Batapati Krishna Reddy J, Bechtold M L. et al. How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review. World J Gastroenterol 2008 14 4011-4019
27. Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995 71 587-591
28. Rosen H R., Jatzko G, Repse S et al. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol 1998 16 2733-2738
29. Sakuramoto S, Sasako M, Yamaguchi T et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007 357 1810-1820
30. Schuhmacher C, Schlag P, Lordick F et al. Neoadjuvant chemotherapy versus surgery alone for locally advanced adenocarcinoma of the stomach and cardia: Randomized EORTC phase III trial #40954. J Clin Oncol 2009 27 4510
31. Scottish Intercollegiate Guidelines Network. Management of Oesophageal and Gastric Cancers. A National Clinical Guideline. Edinburgh June 2006
32. Siewert J R., Böttcher K, Stein H J., Roder J D. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998 228 449-461
33. Sobin L H., Gospodarowicz M K., Wittekind C. UICC: TNM classification of malignant tumors. 7th edition. Oxford Wiley-Blackwell 2009
34. Stahl M, Walz M K., Stuschke M et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009 27 851-856
35. Van Cutsem E, Moiseyenko V M., Tjulandin S et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006 24 4991-4997
36. van Westreenen H L., Westerterp M, Bossuyt P M. et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004 22 3805-12
37. Witzig R, Schönberger B, Fink U et al. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma. Endoscopy 2006 38 1122-1226
38. Yan T D., Black D, Sugarbaker P H. et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007 14 2702-2713
39. Yoon S S., Yang H K. Lymphadenectomy for gastric adenocarcinoma: should west meet east? Oncologist 2009 14 871-882
40. Zhao S L., Fang J Y. The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis. Cancer Invest 2008 26 317-325